Project Farma

Biomanufacturing services for cell and gene therapy

Chicago, Illinois, United States

About Project Farma

Project Farma specializes in biomanufacturing, focusing on cell and gene therapy. The company develops and implements strategies for advanced therapy facilities, helping clients create treatments that modify genes to address diseases. Their services encompass the entire lifecycle of biomanufacturing projects, including facility construction, validation, quality assurance, regulatory compliance, and automation. Project Farma distinguishes itself by offering comprehensive, turnkey solutions that ensure facilities meet Good Manufacturing Practices (GMP), which is essential for producing safe therapies. Their goal is to enhance patient outcomes through effective project execution and they also emphasize philanthropy and professional development within their team.

Chicago, IllinoisHeadquarters
2016Year Founded
ACQUISITIONCompany Stage
Consulting, Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Paid Vacation
Company Paid Maternity and Parental Leave
Continuing Education Assistance

Risks

Emerging biomanufacturing consulting firms increase market competition.
Rapid technological advancements may require significant investment to stay competitive.
Economic downturns could reduce demand from biotech startups.

Differentiation

Project Farma specializes in cell and gene therapy facility builds and compliance.
They offer turnkey solutions, managing projects from planning to execution.
Their focus on philanthropy and professional development sets them apart.

Upsides

Rising demand for cell and gene therapies boosts need for specialized facilities.
Advancements in automation enhance efficiency and cost-effectiveness of services.
Complex regulatory requirements increase demand for Project Farma's consulting expertise.